Annual CFF:
$249.25M+$196.09M(+368.82%)Summary
- As of today, EWTX annual cash from financing is $249.25 million, with the most recent change of +$196.09 million (+368.82%) on December 31, 2024.
- During the last 3 years, EWTX annual cash from financing has risen by +$62.87 million (+33.73%).
- EWTX annual cash from financing is now at all-time high.
Performance
EWTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$1.66M-$186.57M(-99.12%)Summary
- As of today, EWTX quarterly cash from financing is $1.66 million, with the most recent change of -$186.57 million (-99.12%) on September 30, 2025.
- Over the past year, EWTX quarterly cash from financing has dropped by -$1.67 million (-50.23%).
- EWTX quarterly cash from financing is now -99.31% below its all-time high of $241.07 million, reached on March 31, 2024.
Performance
EWTX Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$195.01M-$1.67M(-0.85%)Summary
- As of today, EWTX TTM cash from financing is $195.01 million, with the most recent change of -$1.67 million (-0.85%) on September 30, 2025.
- Over the past year, EWTX TTM cash from financing has dropped by -$104.34 million (-34.86%).
- EWTX TTM cash from financing is now -34.86% below its all-time high of $299.35 million, reached on September 30, 2024.
Performance
EWTX TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EWTX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +368.8% | -50.2% | -34.9% |
| 3Y3 Years | +33.7% | -98.7% | +49.7% |
| 5Y5 Years | +905.0% | - | - |
EWTX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +368.8% | -99.3% | +590.8% | -34.9% | >+9999.0% |
| 5Y | 5-Year | at high | +905.0% | -99.3% | +285.2% | -34.9% | >+9999.0% |
| All-Time | All-Time | at high | +905.0% | -99.3% | +285.2% | -34.9% | >+9999.0% |
EWTX Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $1.66M(-99.1%) | $195.01M(-0.9%) |
| Jun 2025 | - | $188.23M(+8367.4%) | $196.68M(+1790.6%) |
| Mar 2025 | - | $2.22M(-23.2%) | $10.40M(-95.8%) |
| Dec 2024 | $249.25M(+368.8%) | $2.90M(-13.1%) | $249.25M(-16.7%) |
| Sep 2024 | - | $3.33M(+70.7%) | $299.35M(+1.2%) |
| Jun 2024 | - | $1.95M(-99.2%) | $295.80M(+0.5%) |
| Mar 2024 | - | $241.07M(+355.0%) | $294.22M(+453.4%) |
| Dec 2023 | $53.17M(-59.0%) | $52.99M(>+9900.0%) | $53.17M(>+9900.0%) |
| Sep 2023 | - | -$211.00K(-157.2%) | -$159.00K(-100.1%) |
| Jun 2023 | - | $369.00K(+1657.1%) | $129.78M(+0.1%) |
| Mar 2023 | - | $21.00K(+106.2%) | $129.59M(-0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $129.64M(-30.4%) | -$338.00K(-100.3%) | $129.64M(-0.5%) |
| Sep 2022 | - | $129.72M(>+9900.0%) | $130.27M(>+9900.0%) |
| Jun 2022 | - | $179.00K(+145.2%) | $582.00K(+218.1%) |
| Mar 2022 | - | $73.00K(-75.1%) | -$493.00K(-100.3%) |
| Dec 2021 | $186.38M(+55.0%) | $293.00K(+691.9%) | $186.38M(+0.2%) |
| Sep 2021 | - | $37.00K(+104.1%) | $186.09M(+0.0%) |
| Jun 2021 | - | -$896.00K(-100.5%) | $186.05M(-0.6%) |
| Mar 2021 | - | $186.95M(>+9900.0%) | $187.09M(>+9900.0%) |
| Dec 2020 | $120.28M(+385.0%) | - | - |
| Jun 2020 | - | $135.00K(>+9900.0%) | $135.00K(>+9900.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $24.80M | - | - |
FAQ
- What is Edgewise Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Edgewise Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Edgewise Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Edgewise Therapeutics, Inc.?
- What is Edgewise Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Edgewise Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of EWTX is $249.25M
What is the all-time high annual cash from financing for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high annual cash from financing is $249.25M
What is Edgewise Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, EWTX annual cash from financing has changed by +$196.09M (+368.82%)
What is Edgewise Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of EWTX is $1.66M
What is the all-time high quarterly cash from financing for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high quarterly cash from financing is $241.07M
What is Edgewise Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, EWTX quarterly cash from financing has changed by -$1.67M (-50.23%)
What is Edgewise Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of EWTX is $195.01M
What is the all-time high TTM cash from financing for Edgewise Therapeutics, Inc.?
Edgewise Therapeutics, Inc. all-time high TTM cash from financing is $299.35M
What is Edgewise Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, EWTX TTM cash from financing has changed by -$104.34M (-34.86%)